Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
RiverVest Venture Partners
Biotech
Wugen banks $172M for off-the-shelf cell therapies
Wugen reeled in $172 million to advance its memory NK cell platform and propel its lead program through a phase 1/2 trial in acute myeloid leukemia.
Amirah Al Idrus
Jul 15, 2021 7:00am
Arch Oncology scores $105M for anti-CD47 cancer med
Apr 27, 2021 3:59pm
RiverVest Venture Partners closes out a $275M fund
Mar 25, 2021 9:10am
